Inscription Capital LLC Makes New Investment in Cigna Group (NYSE:CI)

Inscription Capital LLC acquired a new stake in Cigna Group (NYSE:CI - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 5,029 shares of the health services provider's stock, valued at approximately $1,827,000.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. TCTC Holdings LLC bought a new position in Cigna Group in the 4th quarter valued at approximately $25,000. Putney Financial Group LLC acquired a new position in Cigna Group in the 4th quarter valued at approximately $36,000. Transce3nd LLC acquired a new position in Cigna Group in the 4th quarter valued at approximately $38,000. Ameriflex Group Inc. acquired a new position in Cigna Group in the 4th quarter valued at approximately $44,000. Finally, Heck Capital Advisors LLC acquired a new position in Cigna Group in the 4th quarter valued at approximately $53,000. Institutional investors own 86.99% of the company's stock.

Analyst Ratings Changes

Several equities analysts have issued reports on the stock. Robert W. Baird decreased their price target on shares of Cigna Group from $388.00 to $362.00 and set an "outperform" rating for the company in a research report on Tuesday, April 15th. Wall Street Zen upgraded shares of Cigna Group from a "buy" rating to a "strong-buy" rating in a research report on Tuesday, April 8th. Morgan Stanley upped their price target on shares of Cigna Group from $379.00 to $390.00 and gave the company an "overweight" rating in a research report on Monday, May 5th. Piper Sandler upped their price target on shares of Cigna Group from $348.00 to $374.00 and gave the company an "overweight" rating in a research report on Monday, May 5th. Finally, Guggenheim restated a "buy" rating and issued a $388.00 price target on shares of Cigna Group in a research report on Friday, May 23rd. Two analysts have rated the stock with a hold rating, sixteen have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, Cigna Group presently has an average rating of "Buy" and a consensus target price of $380.39.

Cigna Group Trading Up 0.6%

Shares of CI traded up $1.83 during trading hours on Thursday, hitting $314.34. 1,170,259 shares of the stock were exchanged, compared to its average volume of 1,715,859. Cigna Group has a fifty-two week low of $262.03 and a fifty-two week high of $370.83. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.72 and a quick ratio of 0.72. The business has a 50-day moving average of $321.79 and a 200-day moving average of $307.93. The firm has a market capitalization of $83.97 billion, a P/E ratio of 17.41, a price-to-earnings-growth ratio of 0.93 and a beta of 0.44.

Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings results on Friday, May 2nd. The health services provider reported $6.74 EPS for the quarter, topping analysts' consensus estimates of $6.35 by $0.39. The business had revenue of $65.45 billion during the quarter, compared to analysts' expectations of $60.39 billion. Cigna Group had a net margin of 1.97% and a return on equity of 18.63%. The business's quarterly revenue was up 14.4% on a year-over-year basis. During the same period last year, the company posted $6.47 earnings per share. On average, research analysts expect that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, June 18th. Shareholders of record on Tuesday, June 3rd were issued a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a yield of 1.92%. The ex-dividend date of this dividend was Tuesday, June 3rd. Cigna Group's payout ratio is 33.44%.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.